Natunola Announces New Funding From Growing Canadian Agri-Innovations Program, Developing Innovative Agri-Products Initiative (DIAP)

WINCHESTER, ON, Jan. 28 /CNW/ - Natunola Health Biosciences Inc. (TSX-V:NHI) ("Natunola") is pleased to announce it has signed an agreement with Agriculture and Agri-Food Canada (AAFC) under the Growing Canadian Agri- Innovations program, Developing Innovative Agri-Products Initiative (DIAP).  Under this collaborative effort, Natunola is providing $60,000 and AAFC is investing $150,000 to conduct research. The DIAP initiative encourages the agricultural-based products sector to develop new or to expand innovation opportunities by providing access to the scientific and technical resources to support enhanced profitability and competitiveness.

"This project will enable Natunola and AAFC research scientists to further research and develop the pilot scale processing for the production of high-value functional ingredients from flaxseed hull," said Dr. Nam Fong Han, President & CEO of Natunola. "The project's main objective is to develop an economic and feasible yet comprehensive processing technology to process flaxseed hulls into lignan concentrates, flaxseed dietary fiber and omega-3 oil components." 

Natunola has licensed the flaxseed hull processing technology from AAFC.

About Natunola Health Bioscience Inc.:

Natunola and its manufacturing plant are located in Winchester, Ontario. Natunola is a manufacturer and researcher in the field of flax seed derived omega-3 fatty acids, flax protein, flax lignans, specialty natural products, bio-nutrients and functional supplements for human and animal care markets. Natunola also produces canola oil gels and other natural ingredients for the cosmetic and personal care industry. Natunola has a retail health product line under the brand name of Natunola® health's delight. Natunola was the winner of AAFC's National Canadian Agri-Food Award of Excellence for Innovation in 2008.

Some of the statements contained in the release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

SOURCE Natunola Health Biosciences Inc.

For further information:

Dr. Nam Fong Han
President & CEO
Natunola Health Biosciences Inc.
661, St Lawrence Street,
Winchester, Ontario.
K0C 2K0
Tel (613) 774-9998


Media Relations
Agriculture and Agri-Food Canada
Ottawa, ON

Organization Profile

Natunola Health Biosciences Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890